Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-151792
Filing Date
2021-05-05
Accepted
2021-05-05 16:38:29
Documents
11
Effectiveness Date
2021-05-05

Document Format Files

Seq Description Document Type Size
1 S-3ASR d124856ds3asr.htm S-3ASR 459315
2 EX-1.3 d124856dex13.htm EX-1.3 13176
3 EX-4.3 d124856dex43.htm EX-4.3 313521
4 EX-4.5 d124856dex45.htm EX-4.5 100277
5 EX-4.6 d124856dex46.htm EX-4.6 100686
6 EX-4.7 d124856dex47.htm EX-4.7 88178
7 EX-5.1 d124856dex51.htm EX-5.1 25813
8 EX-23.1 d124856dex231.htm EX-23.1 1718
9 GRAPHIC g124856g03d10.jpg GRAPHIC 51822
10 GRAPHIC g124856g0504153251466.jpg GRAPHIC 2529
11 GRAPHIC g124856g36d56.jpg GRAPHIC 37335
  Complete submission text file 0001193125-21-151792.txt   1222137
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-255792 | Film No.: 21894019
SIC: 2836 Biological Products, (No Diagnostic Substances)